How Casma Therapeutics Built a FAIR Informatics Ecosystem to Support Rapid R&D Growth
Jarrod Medeiros, leveraging his pharmaceutical and informatics expertise, helped Casma Therapeutics establish a scalable FAIR (Findable, Accessible, Interoperable, Reusable) data ecosystem using Dotmatics to centralize diverse data sources, enable flexible ingestion, and support personalized analysis, thereby laying a robust IT and informatics foundation to accelerate the biotech’s rapid R&D growth focused on novel cellular-degradation drug discovery.
Data is Everything
Jarrod Medeiros, after working in labs at leading pharmaceutical companies such as Novartis, Millennium, and EMD Serono, transitioned from scientist to informatics expert. He later joined Casma Therapeutics, a Cambridge, Massachusetts-based biotech focused on developing small molecule drugs using novel cellular-degradation approaches based on the autophagy pathway. Medeiros' role at Casma centers on delivering informatics and IT solutions to support researchers and their data needs. He joined Casma shortly after its inception in 2018, aiming to lay an IT and informatics foundation to support the company's growth.
Casma’s FAIR Informatics Vision
Casma, having been spun out of healthcare venture Third Rock, started with a central database for assay and compound data, a registration system, and various statistical and data analytics software programs. Medeiros recognized the need to envision what the company's data systems should look like in the future, focusing on creating an ecosystem of FAIR data—data that is Findable, Accessible, Interoperable, and Reusable. This approach not only improves efficiency but also enables researchers to make connections and uncover insights for breakthrough discoveries.
Medeiros identified that isolated, cobbled-together systems would not suffice as Casma grew. He envisioned an IT foundation that enabled:
- Flexible data ingestion: Acquiring data from various sources such as specialty instruments, ELNs, LIMS, and CROs.
- Centralized data storage: Ensuring all structured and unstructured data is interoperable, accessible with proper permissions, and centrally housed.
- Personalizable data analysis: Allowing stakeholders to access and analyze data using their preferred tools, from Excel to advanced analytics packages.
Dotmatics provided the platform to realize this vision.
Laying a Foundation for Growth with Dotmatics
Medeiros implemented a change-management plan to minimize disruption, preserve effective existing systems, and maximize outcomes.
Preparing Existing Systems
Early steps included standardizing data and integrating existing systems to ensure smooth transition into a more complex informatics infrastructure. For example, ensuring IDs from the registration system would carry over into other systems and preparing experimental data for accessibility within the new solution.
Building Off Dotmatics’ End-to-End R&D Platform
Recognizing that Casma's needs would evolve, Medeiros sought an end-to-end R&D data platform that could support diverse workflows, assays, data types, and user needs, while minimizing the need to switch between systems. The platform needed to scale and adapt as requirements changed. Dotmatics was chosen over other market products and in-house solutions.
Dotmatics allowed Casma to evolve their ecosystem gradually, adopting new solutions in phases and preserving existing ones as needed. This approach provided a stable infrastructure for long-term growth and minimized day-to-day interruptions for R&D teams.
Some Dotmatics capabilities implemented at Casma include:
- Electronic laboratory notebook (ELN): A centralized tool for tracking experiment metadata, capturing experiment setup and SOPs, recording and identifying compounds, tracking materials and reagents, capturing and searching experiment results, attaining sign-off, and creating PDF reports.
- Centralized informatics platform: A data warehouse with powerful, forms-based, federated scientific search and various data visualization and analysis tools. Scientists can now find and share ready-to-analyze datasets themselves, without additional help or data cleaning.
- Assay management: Protocols can be added as needed, such as high-content screening workflows with instrument integration. Additional protocols, like SPR and kinetics, are planned for future integration.
- Compound management and registration: Existing systems were linked, with the option to transition to a Dotmatics solution in the future if desired.
Ensuring Success
Medeiros emphasizes the importance of a simple, stepwise approach, flexibility, and user buy-in. Engaging users and leadership in the process, gathering feedback, and communicating the long-term strategy have been critical to the success of the informatics ecosystem at Casma.
"Getting user investment and input has been critical. A lot of time scientists aren’t thinking about the long-term strategy for data because they’re so focused on their experiments at hand; but when you talk to them about the big picture, they always see the value and let you know what will be most impactful for them. We have done a lot of work with our leadership team and scientists to let them know what’s coming and give them the opportunity to provide feedback. This has been critical to the success of this endeavor."
Related
Simplify your laboratory workflow management with Dotmatics
Dotmatics offers a unified scientific R&D platform that streamlines laboratory workflow management by integrating various scientific applications, automating data extraction, cleaning, and harmonization into FAIR formats, thereby reducing manual data handling, enhancing collaboration, and accelerating the R&D cycle to help life sciences organizations bring new therapies to market faster.
The Rise of Biotech: Why Smaller Companies Are Outpacing Big Pharma on Innovation
Smaller biotech companies are increasingly outpacing big pharmaceutical firms in new molecular entity approvals due to their greater agility, willingness to take risks, and freedom to innovate despite funding challenges, with over half of upcoming blockbuster drug launches expected from first-time launchers who face higher risks but also potential for significant success.
Le cahier de laboratoire électronique pour l'entreprise, conçu par des scientifiques pour les scientifiques
Le cahier de laboratoire électronique (ELN) de Dotmatics, conçu par des scientifiques pour des scientifiques, offre un cadre intuitif et sécurisé permettant de capturer, stocker, rechercher et partager divers types de données expérimentales (molécules, réactions, séquences, images, vidéos, texte, données numériques) via des protocoles flexibles, des tableaux de bord intelligents, une intégration avec d'autres applications Dotmatics, et un hébergement cloud favorisant la collaboration interne et externe tout en protégeant rigoureusement la propriété intellectuelle.
A Scientific R&D Platform for Startup Biotech to Large Biopharma
Independent Informatics Consultant Bob Coner leverages Dotmatics' flexible, scalable, and user-friendly scientific R&D platform to help clients ranging from biotech startups to large biopharma companies automate lab data capture, integrate legacy systems, manage diverse research workflows—including electronic lab notebooks, compound registration, inventory, assay data management, and secure cloud storage—ultimately enhancing research decision-making and protecting intellectual property.
2025 Dotmatics Summit: London
The 2025 Dotmatics Summit in London highlighted Dotmatics’ strategic vision to unify scientific software and data through AI-driven, FAIR-aligned tools like the enhanced ELN and Luma platform, showcased customer success with Croda’s global ELN adoption, and featured hands-on sessions demonstrating integrated workflows, advanced data modeling, and interactive dashboards to optimize R&D and lab instrument data management.
Our 11 Most-Read Blogs of 2023: AI, Biologics, ELNs, and More
Dotmatics' top blogs of 2023 highlight key scientific advancements including the convergence of small molecule and biologic drug development, the integration and comparison of LIMS and ELN systems for enhanced lab data management, and strategies to minimize human errors in biologics research through automation and calibration.